Cobalamin J disease detected on newborn screening: Novel variant and normal neurodevelopmental course

Research output: Contribution to journalArticlepeer-review


Cobalamin J disease (CblJ) is an ultra-rare autosomal recessive disorder of intracellular cobalamin metabolism associated with combined methylmalonic acidemia and homocystinuria. It is caused by pathogenic variants in ABCD4, which encodes an ATP-binding cassette (ABC) transporter that affects the lysosomal release of cobalamin (Cbl) into the cytoplasm. Only six cases of CblJ have been reported in the literature. Described clinical features include feeding difficulties, failure to thrive, hypotonia, seizures, developmental delay, and hematological abnormalities. Information on clinical outcomes is extremely limited, and no cases of presymptomatic diagnosis have been reported. We describe a now 17-month-old male with CblJ detected by newborn screening and confirmed by biochemical, molecular, and complementation studies. With early detection and initiation of treatment, this patient has remained asymptomatic with normal growth parameters and neurodevelopmental function. To the best of our knowledge, this report represents the first asymptomatic and neurotypical patient with CblJ.

Original languageEnglish (US)
JournalAmerican Journal of Medical Genetics, Part A
StateAccepted/In press - 2021

Bibliographical note

Publisher Copyright:
© 2021 Wiley Periodicals LLC.


  • ABCD4
  • cobalamin J
  • homocysteine
  • methylmalonic acid
  • neurodevelopment
  • newborn screen

PubMed: MeSH publication types

  • Case Reports

Fingerprint Dive into the research topics of 'Cobalamin J disease detected on newborn screening: Novel variant and normal neurodevelopmental course'. Together they form a unique fingerprint.

Cite this